Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Mar 31;300(6728):869–870. doi: 10.1136/bmj.300.6728.869

Thrombolysis and the general practitioner. 2. Useful after careful evaluation of patients.

R G Wilcox 1
PMCID: PMC1662582  PMID: 2186829

Full text

PDF
869

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chesebro J. H., Knatterud G., Roberts R., Borer J., Cohen L. S., Dalen J., Dodge H. T., Francis C. K., Hillis D., Ludbrook P. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987 Jul;76(1):142–154. doi: 10.1161/01.cir.76.1.142. [DOI] [PubMed] [Google Scholar]
  2. Cobb L. A., Werner J. A., Trobaugh G. B. Sudden cardiac death. I. A decade's experience with out-of-hospital resuscitation. Mod Concepts Cardiovasc Dis. 1980 Jun;49(6):31–36. [PubMed] [Google Scholar]
  3. Davies M. J., Thomas A. C. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985 Apr;53(4):363–373. doi: 10.1136/hrt.53.4.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hall G. H. Bolus streptokinase after myocardial infarction. Lancet. 1987 Jul 11;2(8550):96–97. doi: 10.1016/s0140-6736(87)92755-3. [DOI] [PubMed] [Google Scholar]
  5. Koren G., Weiss A. T., Hasin Y., Appelbaum D., Welber S., Rozenman Y., Lotan C., Mosseri M., Sapoznikov D., Luria M. H. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 1985 Nov 28;313(22):1384–1389. doi: 10.1056/NEJM198511283132204. [DOI] [PubMed] [Google Scholar]
  6. Reimer K. A., Lowe J. E., Rasmussen M. M., Jennings R. B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. doi: 10.1161/01.cir.56.5.786. [DOI] [PubMed] [Google Scholar]
  7. Rowley J. M., Hill J. D., Hampton J. R., Mitchell J. R. Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) 1982 Jun 12;284(6331):1741–1746. doi: 10.1136/bmj.284.6331.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Van de Werf F., Arnold A. E. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ. 1988 Nov 26;297(6660):1374–1379. doi: 10.1136/bmj.297.6660.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES